SRT2183 impairs ovarian cancer by facilitating autophagy

The 5-year survival rate of ovarian cancer patients is only 47%, and developing novel drugs for ovarian cancer is needed. Herein, we evaluated if and how SRT2183, a sirtuin-1 activator, impairs the ovarian cancer cells. OVCAR-3 and A2780 cells were treated with SRT2183. Cell viability was measured b...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Aging (Albany NY)
Huvudupphovsmän: Sun, Tingting, Hu, Yanfen, He, Weipeng, Shang, Yuru, Yang, Xiaohong, Gong, Liyun, Zhang, Xianbin, Gong, Peng, Yang, Guofen
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals 2020
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7762476/
https://ncbi.nlm.nih.gov/pubmed/33223507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.104126
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk